Skip to main content

Table 1 Patient characteristics

From: Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland

Variable

Study population

Variable

Study population

(n = 469)

 

(n = 469)

Age (years)

64.1 ± 11.4

N stage

 

Gender

 

N0

117 (24.9)

 Male

235 (50.1)

N1

65 (13.9)

 Female

234 (49.9)

N2

134 (28.6)

Smoking status

 

N3

153 (32.6)

 Never smokers

115 (24.5)

Extrathoracic metastasis/−es

213 (45.4)

 Ex-smokers

160 (34.1)

M stage

 

 Current smokers

194 (41.4)

M0

168 (35.8)

Clinical stage

 

M1a

88 (18.8)

 I

34 (7.2)

M1b

72 (15.4)

 II

36 (7.7)

M1c

141 (30.1)

 III

100 (21.3)

Localization

 

 IV

299 (63.8)

Right upper lobe

121 (25.8)

T stage

 

Right lower lobe

65 (13.9)

 T1

68 (14.5)

Middle lobe

19 (4.1)

  T1a

9 (1.9)

Left upper lobe

88 (18.8)

  T1b

28 (6.0)

Left lower lobe

73 (15.6)

  T1c

31 (6.6)

Lingula

14 (3.0)

 T2

120 (25.6)

Involvement of two lobes

89 (19.0)

  T2a

81 (17.3)

Distribution

 

  T2b

39 (8.3)

Central

96 (20.5)

 T3

93 (19.8)

Peripheral

323 (68.9)

 T4

188 (40.1)

Central and peripheral

50 (10.7)

Lymph node metastasis/−es

352 (75.1)

Size (mm)

45 ± 25

  1. Data are mean values ± standard deviations for continuous variables and number of patients with percentages in parentheses for categorical variables